Dr. Daniel Desalvo, MD

NPI: 1114187440
Total Payments
$120,940
2024 Payments
$1,241
Companies
7
Transactions
120

Payment Breakdown by Category

Other$85,982 (71.1%)
Consulting$22,438 (18.6%)
Travel$8,310 (6.9%)
Food & Beverage$2,229 (1.8%)
Research$1,983 (1.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $33,814 18 28.0%
Compensation for serving as faculty or as a speaker for a medical education program $26,447 14 21.9%
Honoraria $25,721 11 21.3%
Consulting Fee $22,438 9 18.6%
Travel and Lodging $8,310 28 6.9%
Food and Beverage $2,229 38 1.8%
Unspecified $1,983 2 1.6%

Payments by Type

General
$118,958
118 transactions
Research
$1,983
2 transactions

Top Paying Companies

Company Total Records Latest Year
Dexcom, Inc. $95,234 78 $0 (2024)
Insulet Corporation $24,380 32 $0 (2024)
MannKind Corporation $800.00 4 $0 (2023)
Medtronic MiniMed, Inc. $257.56 2 $0 (2018)
Medtronic, Inc. $146.13 1 $0 (2024)
Tandem Diabetes Care, Inc. $84.00 1 $0 (2017)
Abbott Laboratories $38.94 2 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,241 4 Dexcom, Inc. ($595.00)
2023 $24,165 30 Insulet Corporation ($12,867)
2022 $18,377 15 Dexcom, Inc. ($18,377)
2021 $23,670 17 DEXCOM, INC. ($23,631)
2020 $26,366 26 Dexcom, Inc. ($24,726)
2019 $10,972 9 Dexcom, Inc. ($5,719)
2018 $10,677 12 Dexcom, Inc. ($8,937)
2017 $5,473 7 Dexcom, Inc. ($2,752)

All Payment Transactions

120 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
06/28/2024 Medtronic, Inc. MINIMED 780G (Device) Food and Beverage In-kind items and services $146.13 General
Category: Durable Pump
06/25/2024 Dexcom, Inc. Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $595.00 General
03/18/2024 Insulet Corporation Omnipod (Device) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $250.00 General
Category: Insulin Pump
02/05/2024 Insulet Corporation Omnipod (Device) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $250.00 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $6,000.00 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Travel and Lodging Cash or cash equivalent $361.55 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Travel and Lodging Cash or cash equivalent $302.80 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Travel and Lodging Cash or cash equivalent $245.74 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Travel and Lodging Cash or cash equivalent $245.73 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Travel and Lodging Cash or cash equivalent $103.15 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Travel and Lodging Cash or cash equivalent $96.25 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Travel and Lodging Cash or cash equivalent $78.19 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Travel and Lodging Cash or cash equivalent $60.00 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Travel and Lodging Cash or cash equivalent $35.00 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Travel and Lodging Cash or cash equivalent $35.00 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $28.50 General
Category: Insulin Pump
11/03/2023 Insulet Corporation Omnipod (Device) Food and Beverage Cash or cash equivalent $25.24 General
Category: Insulin Pump
10/30/2023 MannKind Corporation AFREZZA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $200.00 General
Category: DIABETES MEDICINE
10/30/2023 MannKind Corporation AFREZZA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $200.00 General
Category: DIABETES MEDICINE
09/23/2023 Dexcom, Inc. DEXCOM G7 GSS (161) (Medical Supply) Consulting Fee Cash or cash equivalent $4,760.00 General
Category: Endocrinology
06/22/2023 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $112.50 General
Category: Endocrinology
05/31/2023 Insulet Corporation Omnipod (Device) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,000.00 General
Category: Insulin Pump
05/31/2023 Insulet Corporation Omnipod (Device) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $1,000.00 General
Category: Insulin Pump
05/31/2023 Insulet Corporation Omnipod (Device) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $250.00 General
Category: Insulin Pump
05/31/2023 Insulet Corporation Omnipod (Device) Compensation for serving as faculty or as a speaker for a medical education program Cash or cash equivalent $250.00 General
Category: Insulin Pump

Research Studies & Clinical Trials

Study Name Company Amount Records
Evaluating the Safety and Effectiveness of the Omnipod Horizon Automated Glucose Control System in Patients with Type 1 Diabetes Insulet Corporation $1,983 2

About Dr. Daniel Desalvo, MD

Dr. Daniel Desalvo, MD is a Pediatric Endocrinology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1114187440.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Desalvo, MD has received a total of $120,940 in payments from pharmaceutical and medical device companies, with $1,241 received in 2024. These payments were reported across 120 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($33,814).

Practice Information

  • Specialty Pediatric Endocrinology
  • Location Houston, TX
  • Active Since 06/10/2008
  • Last Updated 06/04/2024
  • Taxonomy Code 2080P0205X
  • Entity Type Individual
  • NPI Number 1114187440

Products in Payments

  • DEXCOM G6 CGM SYSTEM (Device) $24,726
  • Omnipod (Device) $24,380
  • DEXCOM G6 TRANSMITTER (Device) $23,631
  • Dexcom G6 Transmitter (Medical Supply) $18,518
  • Dexcom CGM (Device) $14,655
  • DEXCOM G7 GSS (161) (Medical Supply) $10,357
  • Dexcom G5 Mobile CGM System (Device) $2,752
  • AFREZZA (Drug) $800.00
  • Minimed 670G System (Device) $257.56
  • MINIMED 780G (Device) $146.13
  • t-slim insulin pump (Device) $84.00
  • FreeStyle Libre (Device) $38.94

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Endocrinology Doctors in Houston